• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Global Cash Access Holdings

Global Cash Access Holdings

  1. Phase III Study Shows Genentech’s Actemra® (tocilizumab) Maintained Steroid-Free Remission in People With Giant Cell Arteritis (GCA )

    Phase III Study Shows Genentech’s Actemra® (tocilizumab) Maintained Steroid-Free Remission in People With Giant Cell Arteritis ( GCA )

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.